If you are:
FDB Only When Necessary: NO FDA CATEGORY; NEONATAL COMPLICATIONS( RESP,GI,CNS)W/EXPOSURE IN 3RD TRIMESTER
Precaution: LIMITED DATA SUGGEST LOW AMOUNT EXCRETED; INFANT ADVERSE EFFECTS NOT OBSERVED
An adult over 60:
management or monitoring precaution: Neuro/Psych-Higher risk of tardive dyskinesia in the elderly. Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Increased risk of death in senile dementia. Maximum of 8mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Giving trifluoperazine HCL to a child under 12:
management or monitoring precaution: Safety and efficacy not established age <6 years.